|
2
|
|
Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.
(journals.asm.org)
|
Melo C
…
Bosque A
mBio
2026-08-21
|
#antibody
#hiv
#immunotherapy
#cytotoxicity
#exhaustion
|
|
4
|
|
Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.
(linkinghub.elsevier.com)
|
Hegelmaier T
…
Haghikia A
Cell Reports Medicine
2026-08-21
|
#immunotherapy
#autoimmune
#car-t
#myasthenia
#remission
|
|
2
|
|
Efficacy and safety of adding induction therapy for unresectable NSCLC receiving cCRT and consolidation immunotherapy: A retrospective study.
(linkinghub.elsevier.com)
|
Meng Y
…
Wang L
iScience
2026-08-21
|
#immunotherapy
#nsclc
#induction
#chemoradiotherapy
#survival
|
|
2
|
|
Prophylactic radiotherapy, reshaping the immune microenvironment: Effects, mechanisms and clinical applications for preventing tumor metastasis.
(linkinghub.elsevier.com)
|
Liu J
…
Liu Y
iScience
2026-08-21
|
#radiotherapy
#immunotherapy
#tumor
#metastasis
#microenvironment
|
|
2
|
|
Adjuvant and neoadjuvant therapies in HCC: Time to go perioperative?
(linkinghub.elsevier.com)
|
Pantzios S
…
Elefsiniotis I
iScience
2026-08-21
|
#hepatocellular carcinoma
#immunotherapy
#adjuvant
#neoadjuvant
#checkpoint-inhibitors
|
|
7
|
|
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.
(linkinghub.elsevier.com)
|
Silverberg JI
…
Warren RB
The Lancet
2026-08-21
|
#dermatitis
#clinical trial
#immunotherapy
#inflammation
#autoimmune
|
|
4
|
|
PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.
(linkinghub.elsevier.com)
|
Lin L
…
Haikala HM
Cell Reports Medicine
2026-08-21
|
#lung cancer
#immunotherapy
#drug combination
#amr
#apoptosis
|
|
6
|
|
Rewiring immunity with in vivo CAR T cell engineering.
(nature.com)
|
Slaney CY
…
Darcy PK
Nature Cancer
2026-08-21
|
#immunotherapy
#car-t
#oncology
#engineering
#lymphocyte
|